Related Experiment Videos
Alteration of rat Kupffer cell function following mitomycin-C administration
H Bodenheimer1, C Charland, J Leith
1Rhode Island Hospital, Department of Medicine, Providence 02902.
Journal of Leukocyte Biology
|March 1, 1988
Summary
Mitomycin-C temporarily impairs rat Kupffer cell function, affecting phagocytosis and C3b receptor binding. This immune suppression, crucial for cancer chemotherapy, recovers within four weeks post-treatment.
Area of Science:
- Immunology
- Pharmacology
- Cell Biology
Background:
- Cancer chemotherapeutic agents can modulate the immune system, causing immunosuppression or immunostimulation.
- Understanding the specific effects of these agents on immune cells is vital for managing host defense during cancer treatment.
Purpose of the Study:
- To evaluate the impact of mitomycin-C on key rat Kupffer cell functions.
- To assess changes in phagocytosis, C3b receptor binding, and lysosomal enzyme activity following mitomycin-C administration.
Main Methods:
- Isolated highly pure rat Kupffer cell cultures (>95%).
- Measured phagocytosis of IgG-coated sheep red blood cells.
- Assessed C3b receptor binding of IgM and complement-coated sheep red blood cells.
- Determined lysosomal enzyme activity.
- Monitored colonic histology at various time points post-treatment.
Main Results:
- Mitomycin-C significantly reduced Kupffer cell phagocytosis (84% to 25%) and C3b receptor binding (88% to 47%) at two weeks post-administration.
- These functions returned to control levels by four weeks.
- Lysosomal enzyme activity remained unaffected by mitomycin-C.
- Histological examination revealed transient severe colon ulceration, which healed by four weeks.
Conclusions:
- Mitomycin-C causes a temporary but significant depression in rat Kupffer cell macrophage function.
- This impairment in immune cell activity may have clinical implications for host defense against infections and tumor spread.
- Immune function recovery occurs within four weeks of mitomycin-C treatment.